The constitutive PI3K/AKT/NF-κB pathway is upregulated in chemoresistance-resistant cell lines and leads to treatment failure, which may be related to the inhibition of apoptosis and promotion of tumor growth by NF-κB59. The gene discussed is PIK3CA; the disease is neoplasm.